Bactobio
EMEA
London
,
United Kingdom
Startup
FOUNDED
2020
HEADCOUNT
21-100
FUNDING
Seed
Keywords:
bacteria, AI/ML, synthetic_biology, omics, therapeutics, crop_protection
BUSINESS
Cultures previously unculturable microbes using genomics, machine learning, and bioengineering to discover novel antimicrobials for healthcare and plant protection. Uses synthetic biology, next-generation sequencing, and machine learning to culture the ~99% of soil microbes that have previously been unculturable, then screens them for novel bioactive metabolites. Primary targets: novel antibiotics against AMR pathogens and sustainable crop protection (fungicides). Bioactivity-driven, target-agnostic natural product discovery approach.
BIOTECH INVOLVEMENT
Core; cultures previously unculturable soil microbes (the ~99% missed by conventional methods) using genomics and machine learning, then deploys synthetic biology to discover novel antimicrobials for healthcare and crop protection.
TECHNOLOGY PLATFORM
genomics; machine learning; bioengineering; synthetic biology
PRIMARY PRODUCTS
novel antimicrobials; biodegradable chemistries; plant protectants